Register Now for The Outlook on Active Nutrition
News|Articles|April 7, 2026

Vitaquest Announces Tim Condron as New Chief Executive Officer

Author(s)Erin McEvoy
Listen
0:00 / 0:00

Key Takeaways

  • Tim Condron’s appointment reflects emphasis on regulatory-grade operational rigor and scalable manufacturing across multiple dosage forms, supported by engineering training and Six Sigma Master Black Belt credentials.
  • At BestCo, Condron upgraded quality systems and compliance to meet FDA drug and dietary supplement requirements, demonstrating capability to execute complex regulated-environment transformations.
SHOW MORE

The leadership transition highlights the company’s intent to scale its operations while maintaining a commitment to customers and innovation.

Vitaquest International LLC, a contract manufacturer for dietary supplement and functional food brands, has appointed Tim Condron as its new Chief Executive Officer, a leadership transition aimed at accelerating commercial and operational growth. The appointment, effective April 1, 2026, signals the company’s continued focus on operational excellence, customer-centered innovation, and scalable manufacturing capabilities, an April 6 news release from the company explains.1

A member of CK Life Sciences International, Inc., Vitaquest International LLC provides services spanning formulation, product development, manufacturing, packaging, and fulfillment across a wide range of dosage forms, including capsules, tablets, powders, and specialty delivery systems.

Growth of the Company

Condron brings more than 20 years of executive leadership experience in regulated manufacturing environments, with a track record of scaling operations and driving commercial performance. Most recently, he served as President and Chief Operating Officer at BestCo Inc., where he led a significant transformation of the organization’s quality and regulatory infrastructure. Under his leadership, BestCo evolved from a confectionery manufacturer operating under food-grade standards into a business compliant with FDA drug and dietary supplement regulations. This transition required substantial upgrades to quality systems, operational processes, and supply chain capabilities.

In addition to his regulatory and operational expertise, Condron expanded commercial relationships with major consumer packaged goods (CPG) brands and retailers across multiple channels, including food, drug, mass, and club. His combined technical and commercial background is supported by training as a chemical engineer and certification as a Six Sigma Master Black Belt.

Alan Yu, Deputy Chairman of CK Life Sciences, commented on Condron’s appointment to the position. “Tim’s combination of regulatory expertise, operational rigor, and commercial leadership makes him ideally suited to build on the strong foundation Vitaquest has established,” he stated. “We are confident he will accelerate the company’s growth, deepen customer partnerships, and continue to deliver exceptional value across the organization.”

The Company’s Strategy for the Future

Looking ahead, Vitaquest’s 2026 strategy is centered on three core priorities: increasing customer-centricity, accelerating innovation, and strengthening its position as an employer of choice. Condron emphasized a forward-looking approach for the company’s future, one focused on collaboration and innovation. “Vitaquest has built a strong reputation for quality, innovation, and partnership across the supplement industry,” he stated. “As we move forward, our focus is clear: putting our customers at the center of everything we do, delivering disruptive innovation that fuels their growth, and continuing to build a workplace where our people can thrive. I look forward to working closely with our customers and our team to shape the next chapter of Vitaquest’s success.”

Condron succeeds Patrick Brueggman, who is retiring after eight years of leadership. Brueggman will remain involved in an advisory capacity, providing continuity and strategic guidance during the transition.

Vitaquest has more than 45 years of industry experience and a platform anchored by its TotalQ quality commitment.

New Manufacturing Facility

Earlier this year, Vitaquest announced another new development: a new Probiotics Manufacturing Suite, located in New Jersey.2 The new suite enables formulation with additional probiotic strains, new product concepts, and personalized wellness solutions, and aims to address both customer needs and market growth in the long term. Additionally, the facility was built to exceed global quality standards.

Interest in probiotics spans not just digestive health, a news release from the company explained, but also immune, cognitive, and overall wellness applications.

This article was created with assistance from AI. The content has been reviewed and edited by Erin McEvoy, Associate Editor. For more information on the extent and nature of AI usage, please contact us.

References

  1. Vitaquest. Vitaquest International Appoints Tim Condron as Chief Executive Officer. News release provided via email April 6, 2026. Accessed April 7, 2026.
  2. McEvoy E. Vitaquest expands probiotics capacity with new manufacturing facility. Published February 3, 2026. Accessed April 7, 2026. https://www.nutritionaloutlook.com/view/vitaquest-expands-probiotics-capacity-with-new-manufacturing-facility